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Abstract 
Introduction:  Cell  wall  mycolic  acids  (MA)  from  Mycobacterium  tuberculosis  are 
presented as antigens that can be used to detect antibodies as surrogate markers of active 
Tuberculosis  (TB)  disease,  even  in  HIV  coinfected  patients.  The  use  of  the  complex 
mixtures  of  natural  MA  is  complicated  by  apparent  antibody  cross-reactivity  with 
cholesterol. Mycolic acid is not only related to diagnosis of TB disease but also similar 
structure of mycolic acid in saprophyte strains are excellent candidate for drug delivery 
especially for nasal spray. The aim of this work was to investigate the effect of cholesterol 
on mycolic acid synthesis and potential of saprophyte mycolic acid to drug delivery.  
Materials and methods: Toluene enrichment medium was used for isolation of mycolic 
acid  producing  bacteria.  A  fast  growing,  acid  fast  bacterium  was  identified  by  PCR 
reaction and the related sequence of 16S rRNA gene was deposited in the NCBI Genbank 
with accession number jn64433. Production of mycolic acid was investigated by high-
performance liquid chromatography (HPLC) in different media.
  
Results: Here the effect of cholesterol on biosynthesis of mycolic acids by saprophyte 
Mycobacterium isolated from marine water is was reported. HPLC analyses showed the 
mycolic acid extracted from saprophyte. Mycobacterium had one, early, cluster of peaks, 
like  Mycobacterium  tuberculosis  and  Mobacterium  bovis.This  strain  is  a  fast  growing 
bacterium and cholesterol might promote longer fatty acid production.
  
Discussion  and  conclusion:  The  similarity  between  mycolic  acid  from  isolated  and 
patogenic mycobacteria offers that mycolic acid obtained from saprophyte Mycobacterium 
can be useful as a drug carrier. Addition of egg yolk to media induced longer fatty acid 
production by isolating that is suitable for delivery of drugs into the macrophage.  
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Introduction 
 
Mycolic  acids  are  found  in  species  of 
Corynebacterium, Nocardia, Rhodococcus, 
and Mycobacterium. These fatty acids have 
been isolated and used for Mycobacterium 
tuberculosis  identification  (1).  Their 
common  structure  was  published  in  1950 
and shown to be formed of a hydroxy and 
alkyl  branched  chain.  The  species  of 
Mycobacterium  tuberculosis  and  M.leprae 
are  the  most  known  species  of 
Mycobacterium  genus  which  are  the 
causative  agents  tuberculosis  and  leprosy. 
Nevertheless  most  of  other  Mycobacteria, 
found  in  the  environment,  are  non 
pathogenic and fast growing strains (2).  
Mycolic acids  present  in  the outer  cell 
membrane  of  the  Mycobacteria  represent 
up  to  %40  of  cell  wall  dry  mass. 
Hydrophobic  compounds  architecture  of 
the mycolic acid plays an important role in 
cell  structure  and  is  essential  for 
Mycobacterial growth. 
Mycolic  acid  covalently  bonded  to  the 
arabinogalactan.  Arabinogalactan-mycolate 
linked with the other component in the cell 
wall to form a thick layer with an extremely 
low  fluidity.  This  barrier  protects  the 
Mycobacteria from hydrophilic agents (3). 
Mycolic  acid  is  a  key  component  for  the 
survival of M.tuberculosis for example low 
permeability  of  MA  doesn’t  allow  to 
hydrophobic  drugs  such  as  general 
antibiotics to inter the cell. M. tuberculosis 
grows  inside  the  macrophages,  so  this 
bacterium  is  responsible  for  substantial 
health  problems  by  effect  on  immune 
system  (4,  5).  Each  species  of 
Mycobacteria  has  a  specific  MA  as  a 
mixture  of  structurally  related  molecules. 
Although biosynthesis pathway of MA was 
shown  to  be  similar  in  different 
Mycobacterial  species,  the  proximal  and 
distal  position  of  meromycolic  carboxyl 
group  is  different  in  each  species  (3,  4). 
Precursors of mycolic acid have long fatty 
acids with different functional groups, such 
as  double  bonds,  keto,  ester,  epoxy, 
methoxy,  and  cyclopropane  ring.  All  the 
sub-classes of this fatty acid do not exist in 
all species but methoxy and keto  are less 
than alpha in most organisms. During the 
exponential growth phase the production of 
keto mycolic acid is more than exponential 
phases  (5,  6).  The  genera  which  has 
mycolic acid, posses a broad family of over 
500  species,  that  several  remarkable 
differences such as the length of fatty acid 
and  the  number  of  carbon  atoms  are 
important  for  their  identification.  In 
Mycobacterium species the most prominent 
fatty acid, posses 60-90 carbon atoms that 
provide  a  crucial  barrier  for  the  cell. 
However,  other  genera  such  as  Nocardia 
and  Corynehbacterium  contain  no 
cardiomycolic  and  corynemycolic  acids 
with  carbon  atoms  between  22-60  units. 
Nocardiomycolic  acid  has  44-60  and 
corynemycolic acid has 22-36 carbon atoms 
(4). 
Acetyl-CoA and malonyl-CoA are initial 
substrates for biosynthesis of mycolic acid, 
and  FAS-I  and  FAS-II  systems  are  two 
systems  for  MA  biosynthesis.  FAS-I 
system  elongates  acetyl-CoA  by  two 
carbon units. The yield of first reaction is 
butyryl-CoA,  and  then  C-16  and  C-18 
derived.  Generally  these  fatty  acids  are 
used  for  synthesis  of  membrane 
phospholipids,  but  in  M.  tuberculosis, 
continued elongation of C-16 and C-18 by 
FAS-I system,  leads  to produce C-20 and 
C-26  products.  The  C-20  fatty  acid  is 
introduced to FAS-II system (7). 
Mycobacteria  are  evolved  in 
biodegradation  of  some  xenobiotic 
substances. Toluene and xylene degradation 
have  seen  in  M.tuberculosis,  also  two 
toluene-degrading  strains,  Mycobacterium 
aurum  and  Mycobacterium  komossense, 
were  isolated  from  rock  surface  in  a 
freshwater  stream  contaminated  with 
toluene.  The  strains  exhibit  different 
capacities  for  degradation  of  toluene  and 
other  aromatic  compounds  and  have 
characteristics of the genus Mycobacterium. 
They  have  mainly  straight-chain  saturated  
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and mono unsaturated fatty acids with 10 to 
20  carbon  atoms  and  large  amounts  of 
tuberculostearic  acid  that  are  typical  of 
Mycobacteria.  Ecological  studies  reveal 
that toluene contamination has enriched for 
toluene-degrading  bacteria  in  the  epilithic 
microbial  community.  Biodegradation  of 
phenanthrene,  fluorene,  fluoranthene, 
pyrene,  vinyl  chloride  and  morpholine  by 
Mycobaterium  have  been  reported 
previously  (8-  11),  however  usually  this 
xenobiotic  does  not  affect  on  fatty  acid 
syntheses. 
Today this fatty acid is a good candidate 
for  drug  delivery.  Nano-encapsulation  of 
anti-TB  drugs  was  successfully 
encapsulated four first line anti-TB drugs: 
Isoniazid  (INH),  Rifampicin  (RIF), 
Ethambutol  (ETB)  and  Pyrazinamide 
(PZA), as well as two second line TB drugs 
(MDR  –TB  drugs),  namely:  Capreomycin 
and  Kanamycin,  in  particles  of  250-400 
nm, using a novel multiple emulsion spray-
drying  technique  (11).  These  drugs 
penetrate better to damaged tissue. Natural 
polymers like chitosan, alginate, and PLGA 
alternative  system  has  been  used  to  the 
current  anti-tuberculosis  nano-drug 
delivery.  The  current  anti-tuberculosis 
nano-drug  delivery  has  been  used 
mycolonic acid as fatty acid drug carrier. 
This study describes the isolation and 
identification of toluene-degrading strain of 
Mycobacterium species from Persian Gulf 
and characterization of cell wall mycolic 
acid and its similarity to others for possible 
drug delivery. 
 
Materials and Methods 
Sampling 
 
For  screening  and  isolation  of  toluene 
degrading bacteria, samples were collected 
from Persian Gulf water and transferred to 
lab in ice box. 
 
Isolation and selection of toluene degrading 
bacteria 
 
A solid mineral medium (MM) was used 
for  the  isolation  of  toluene  degrading 
bacteria.  This  medium  contained  (gl
-1): 
KH2PO4,  4;  Na2HPO4,  4;  NH4Cl,  2; 
MgSO4, 0.2; CaCl2, 0.001 and FeCl3, 0.001 
in 1000 mL. distillated water and pH was 
6.8.  Toluene  was  added  in  sterile  MM 
media by 1% (v/v). About 10 mL seawater 
was  centrifuged  and  1  mL.  of  pellet  was 
spread  onto  the  toluene  agar  (mineral 
medium with toluene as the only sources of 
carbon and energy). Plates were incubated 
at  28°C.  After  2  weeks  of  enrichment, 
cream colony was isolated on nutrient agar. 
This  isolate  must  be  salt  and  toluene 
tolerant  bacterium.  The  sample  did  not 
dilute since there were few microorganism 
that tolerated the solvent toluene. 
 
Identification of the isolates 
 
Identification of the isolated strain was 
performed  based  on  colony  morphology, 
microscopic observation  of the  cell  cycle, 
Gram stain, acid-fast stain, the catalase test, 
the  oxidase  test,  oxygen  requirement, 
motility and the ability to grow on different 
carbon sources  according to  the standards 
of microbial identification (17) 
DNA  was  extracted  for  PCR  reaction 
from culture by boiling. The samples were 
centrifuged at 10,000 rpm for 15 min. Cells 
are washed triple by water. The pellet was 
twice  freezed-thaw  and  resuspended  in  1 
mL. of molecular biology-grade water and 
boiling at 100°C in a water bath for 15 min, 
centrifuged at 10,000 rpm for 5 min, and 
the supernatant was used for PCR. The 16S 
rRNA gene for identification of the toluene 
utilizing strain was amplified with DG74-
AGGAGGTGATCCAACCGCA  as  a 
forward  primer  and  RW01-
AACTGGAGGAAGGTGGGGAT  as  a 
backward primer (12). The amplified PCR 
product is approximately 370 bp in length. 
Amplification reactions were done in a 25 
μl  reaction  volume.  Reaction  tubes 
contained 1 μl of each primer-pair (0.3 μg 
μl
-1), 0.5 μl dNTPs (0.2 mmol l
-1), 2.5 μl 
X10 PCR buffer, 0.75 μl MgCl2 (25 mmol 
l
-1), 17 μl PCR H2O, 2 μl template DNA 
extracted from bacterium and 0.25 μl Taq  
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polymerase  (5U  μl
-1  ).  The  PCR  reaction 
was  performed  in  an  Eppendorf  Thermal 
Cycler  using  appropriate  programs 
optimized  for  this  primer.  After 
denaturation of DNA through heating for 2 
min at  94°C, The PCR  program  involved 
30  cycles,  each  cycle  consisted  of: 
denaturation at 94°C for 2 min, annealing at 
55°C for 1 min and extension at 72°C for 1 
minute.  This  was  followed  by  a  final 
elongation step for 2 min at 72°C. The PCR 
products were separated on a 1.7% agarose 
gel  containing  ethidium  bromide  in  1  × 
TBE buffer, run at 100 V for 1.5 h and the 
gel  was  visualized  on  a  UV 
Transilluminator.  The  purified  PCR 
product  was  sequenced  in  both  directions 
using an automated sequencer by Macrogen 
(Seoul, Korea). The sequences were edited 
using Finch TV V.1.4.0., and the BLASTN 
program  was  used  for  homology  searches 
with the standard program default. 
 
Growth in nutrient broth and egg media? 
 
Isolated Mycobacterium was  inoculated 
in  nutrient  broth  (Sigma)  and  liquid 
Lowenstein-Jensen  (Merk)  medium  (L.J) 
contained (g/1600 mL): potato starch,  30; 
asparagines, 3.6; KH2PO4, 2.4; magnesium 
citrate,  0.6;  MgSO4. 7H2O,  0.24;  10  mL; 
glycerol, 12 mL; Homogenized whole egg, 
in 600 mL distillated water. Cultures were 
grown at 25°C with continuous shaking, for 
10 days (3). After this time, samples were 
checked for purify. 
 
Extraction and analysis of mycolic acid 
 
Lipids  were  extracted  from  cells  using 
the method described by Rafidinarivo et.al 
(3).  The  cells  were  harvested  by 
centrifugingt  at  4000  rpm  for  15  min. 
Mycolic acids were extracted from 20 gr of 
wet cells with 10mL chloroform/methanol 
(1:2, v/v) for 17 h at room temperature with 
continuous  stirring. The residues were  re-
extracted for 23 h with 10 mL chloroform/ 
methanol  (1:1,  v/v)  were  added  residues, 
for 17 h under the same conditions. After 
mixing  and  centrifuging  at  6000rpm  for 
10min, organic phase of nutrient broth and 
bottom phase of L.J medium were pooled 
and  were  analyzed  with  HPLC.  For  the 
chromatographic  separation,  an  HPLC 
instrument  equipped  with  a  reverse  phase 
C18  Ultrasphere  XL  analytical  cartridge 
column and with a detector set at 254-260 
nm. The gradient of solvents, methanol (M) 
and  methylene  chloride  (MC),  is  changed 
from  the  initial  conditions  (98%  M:2% 
MC) to 80% M:20% MC. 
 
Results 
 
The  isolated  Mycobacterium  from 
marine  water  was  enriched  with  toluene 
and isolated on nutrient agar. The isolated 
bacterium had cream colony, growed fast in 
compare  with  other  Mycobacteria  and 
visible colonies were observed after 4 days 
incubation  at  28°C  on  nutrient  agar.  In 
compare with other Mycobacterium it is a 
rapid grower strain. It was catalase positive, 
non motile, rod shaped acid fast bacilli with 
metachromatic  granules  (Fig.  1),  using 
universal  primer  was  identified  as 
Mycobacterium sp. and has been submitted 
to NCBI with accesses number of jn64433. 
The cells were grown on nutrient broth and 
egg  liquid  media  for  10  days.  Then  the 
grown cells were harvested and in several 
steps  the  mycolic  acid  was  extracted  and 
identified  by  HPLC  (Fig.  2  A  and  B). 
Mycobacterium bovis (13) had one cluster 
of  peaks  and  isolated  toluene  degradator 
Mycobacterium  had  one  early  cluster  of 
peak according to figure 2B. The interface 
of  Mycobacterium  bovis  and 
Mycobacterium tuberculosis to target cells 
are through similar mycolic acid which is 
the same as the isolated one, however the 
other  toluene  degrading  Mycobacterium 
had different pattern of mycolic acid. It was 
interesting that the only difference between 
the additions of egg yolk was the highest 
peak  at  3  min  whereas  in  nutrient  broth 
grown on the highest peaks, was at 1.5 min. 
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Fig. 1- A- Gram stain of isolated fast growing Mycobacterium and B- The PCR product of 16S rRNA gene. 
 
 
 
 
 
Fig. 2- A- The early first cluster of peaks of Mycobacterium bovis showen by Floyd et.al. in 1992, (13). B- Similar 
fatty acid pattern analyzed by HPLC are shown for isolated Mycobacterium 
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The  result  of  present  study  offers  that 
the  production  of  different  secondary 
metabolites can be induced by changing in 
culture  ingredients  to  produce  longer 
mycolic acid chains. 
 
Discussion and conclusion 
 
Mycolic acid is an essential component 
for  survival  of  M.tuberculosis.  For 
example,  low  permeability  of  this 
compound  doesn’t  allow  to  hydrophobic 
drugs such as general antibiotics to inter the 
cell,  or  make  them  resistant  to  acid  and 
solvents  although  acid  and  solvents  may 
change the structure of this fatty acid. The 
drug  delivers  are  liposomes,  polyhydroxy 
butyrate  or  heavy  chain  of  mycolic  acids 
(14). Therefore production of mycolic acid 
from  a  non  pathogen  Mycobacterial  is 
useful  for  introducing  ways  in 
identification  of  Mycobacteria  (4), 
promoting  second  metabolite  synthesis, 
drug deliveries (14) and inhibition of fatty 
acid  synthesis  (7).  Here  synthesis  of  long 
fatty acids in presence of cholesterol by a 
salt and toluene tolerate Mycobacterium is 
reported. 
One  of  the  challenges  of  Tuberculosis 
treatment is non-specific localization of the 
drugs  into  the  body  leads  to  reduction  of 
their effectiveness due to decrease of drug 
concentration  in  target  site  of  infection. 
Recent advances in intelligent drug delivery 
techniques  cause  effective  cure  for  more 
infections. M. tuberculosis entry into host 
macrophages  are  adapted  to  survive  in 
these cells (15). 
Paradoxically,  macrophages  are  the 
primary effector cells of the innate immune 
response. Nowadays, there are many drugs 
that  inhibit  specific  enzymes  which  are 
involved  in  the  biosynthesis  of 
Mycobacterial cell wall (15). Mycolic acid 
can be used as drug delivery and can mimic 
antigenic  structure  of  tuberculin  too.  This 
lipid is not soluble in water, Therefore, to 
overcome  the  poor  solubility  of  MA  in 
water, the bio-lipid  has  been incorporated 
into liposome as vehicles for drug delivery 
(16, 17). MA derivatives from saprophytic 
Mycobacteria,  which  are  capable  to  resist 
the  environmental  condition  (salt  and 
solvents), are more stable. These fatty acids 
are suitable for delivery of drugs into the 
body and target them to the macrophage.  
MA can insert to the peritoneal cavity or 
to  the  alveolar  macrophage,  similar  to 
entering  of  M  tuberculosiss  observed  in 
tuberculosis granulomas (4). The previous 
studies observed uptake of long-chain fatty 
acids  from  the  culture  medium  by 
Mycobacteria  and  incorporation  into 
triacylglycerol. C16 and C18 fatty acids in 
M.  tuberculosis,  could  be  used  for  the 
mycolic acids synthesis by entrance to the 
FAS-I pathway (7). 
Also  using  of  mycolic  acid  as  capsule 
for drug can inhibit mycolic acid synthesis 
in  pathogenic  Mycobacterium  which  can 
efficiently  inactivate  pathogenic 
Mycobacteria.  Our  result  indicated  that 
changes  in  the  culture  medium  of 
saprophytic  Mycobacterium  isolated  from 
marine  environment,  had  an  influence  on 
the  mycolic  acid  component  (Fig.  3), 
probably  due  to  the  effect  of  culture 
ingredient on activity of FAS-I and FAS-II 
systems (7). 
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Fig. 3- The HPLC of mycolic acid obtained from Mycobacterium grown on egg yolk media (A) and cholesterol 
free media (B) 
 
 
In the present study, we suggest that MA 
from  a  saprophytic  toluene  tolerate 
Mycobacterium has long fatty acid chain in 
presence of cholesterol and could be useful 
for  treatment  of  Mycobacterial  infection. 
According  to  the  results,  this  isolated 
Mycobacterium are resistant to salt, toluene 
and pattern of cell wall mycolic acids were 
similar to pathogenic Mycobacterium. 
Also  Mycolic  acid-containing  bacteria 
can influence the biosynthesis of complex 
natural  products  in  Streptomyces  species 
(16).  Each  mycolic  acid-containing  strain 
induces  different  changes  in  secondary 
metabolism  production  (5).  So,  mycolic 
acid from non pathogen strain may promote 
Streptomyces for new drug syntheses. 
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چ هدي֩  
همدقم  : ان׌  ر  هي اا׌سا ֩׌لن֩׌ام ر ه   ׌تتنا  تمانع ارا  ، را  رنضر س׌زنليربن   ن׌رتيابن֩׌ام ׌لنلس ا   ׌تن֘
׌م هي تسا  اارب ׌׌اهراناشن ناننع هب اننان  ׌تنا ׌با׌ ر ا اب   اننتش ه ا تتسا س׌زنليربن  لاع، ارام׌ب ااه  .   ׌بات׌ ر
׌تنا ׌تنا طسن  ا اب ن֘ تنن ع ر  ׌تر ا׌سا ֩׌لن֩׌ام ااه ׌م زا׌ا ارام׌ب اب هارمه ااه  هتب انان      نتش هتت،ر֯ راتي  .
هعنمجم زا ه ا تسا ׌تنا عطاقتم شنياو ثعاب تسا ن֩مم اها׌سا ֩׌لن֩׌ام زا اا  رتتسلي اب ا اب   نت׌ا زا و  نتش لو  ور
اشاب ز׌انا هرطاخم  . ن׌ا رب هواع ׌م ا׌سا ֩׌لن֩׌ام هي   ، نتش ه ا تسا س׌زنليربن  ارام׌ب ׌ئاسانش اب طاب را ر  انان 
ه׌نس ا׌سا ֩׌لن֩׌ام ارام׌بر׌غ ااه ׌م از هن׌ز֯ اننان        اتن׌ا׌ب  اتسر هتب ورا  لاتقتنا اارتب ׌بنتخ را׌سب ا  .    ه اتم نت׌ا
هب    ارپسا اارب صنصخ  ׌تم ׌ن׌ب ق׌رط زا نا لاقتنا و ورا     اتشاب اتماراي اتنان   .    قت׌ق׌  نت׌ا زا  اته ،      ر׌رات  ׌تسررب
 ورا  لاقتنا اارب نا  ׌سناتپ و ا׌سا ֩׌لن֩׌ام زتنس رب لورتسلي تسا  .  
شور و داوم    اه :   لابرغ رنظنم هب   ارتياب ار֯  اتش ه ا تسا نئنلن  زا ׌نغ ط׌׌م زا ا׌سا ֩׌لن֩׌ام هاننيا׌لن  ااه  .
 ֩׌            ور  زا  ه ا تتسا  اتب  و  ازاتسااف  ع׌رتس  اتشر  اتب  تتسا،ا׌سا  ارتياتب PCR     اتش ׌ئاتسانش  .    ن֘ هتب طنتبرم ׌لانت   
16S rRNA    ׌با׌تس  هرامش اب ارتياب ن׌ا jn64433    ׌ن֘ ֩ناب ر  NCBI    ط׌ت׌م ر  ا׌سا ֩׌لن֩׌ام ا׌لن  و تبر   ااته
اراي اب ع׌ام ׌،ار֯ن اموري زا ه ا تسا اب فلتخم ׌ لااب ׌ ( (HPLC   اش ׌سررب .    
جياتي :   هعلاطم ن׌ا ر  ،   ارام׌بر׌غ ه׌نس ֩׌ طسن  ا׌سا ֩׌لن֩׌ام زتنسن׌ب رب لورتسلي ر׌را   ا زا هي از   ׌׌ات׌ر  ااه
 ׌سررب تسا هاش ازاسااف اش  .  تاعلاطم HPLC   ׌م ناشن  ֩׌پ هتس  ֩׌ هاش ازاسااف ه׌نس ا׌سا ֩׌لن֩׌ام اه 
ه׌لوا   ااها׌سا ֩׌لن֩׌ام ر  ׌֯֘׌و ن׌ا هي  را    ارتياب  ز׌ن س׌نب  ن׌رتيابن֩׌ام و س׌زنليربن   ن׌رتيابن֩׌ام ااه
׌م ها׌   نش  . ه׌نس ׌م لورتسلي و  را  ׌ع׌رس اشر هاش ازاسااف ا         ت׌نط  رتط ااها׌تسا ات׌لن  ترت׌م اتنان 
اشاب نا ر  هر׌جنز  .  
هجيتي و ثحب   يري֯ :       اراتم׌بر׌غ ه׌نتس ا׌تسا ֩ت׌لن֩׌ام ن׌ب تهابش    ֩׌ام اتب هاتش ازاتسااف ااز   ن׌رتياتبن   ااته
ارام׌ب ׌م ار  ا نش׌پ ن׌ا از ه׌نس زا هي اا׌سا ֩׌لن֩׌ام هي اه  ارام׌بر׌غ ا    ׌تم تتسا هاتش ازاسااف از    هتب اتنان 
 نش ه ا تسا ورا   قان ناننع  . ه رز ن ري ه،اضا  لنط اب  رط ااها׌سا ا׌لن  ااقلا ثعاب ،تشي ط׌׌م هب غرم مخ  ا
׌م انلب ׌م تلار ن׌ا هي  نش ب انان  اشاب بسانم اه֘ا،وريام هب ورا  لاقتنا اار .    
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